Singapore markets closed
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
63,500.22 -2,904.55 (-4.37%) CMC Crypto 200
1,350.18 -32.39 (-2.34%)
ABBV Jun 2024 160.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:36PM EDT. Market open.
| Previous close | 2.5100 |
| Open | 2.6400 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 160.00 |
| Expiry date | 2024-06-21 |
| Day's range | 2.4600 - 2.6400 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Zacks4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
© 2024 Yahoo. All rights reserved.